Report Overview

The EU Atopic Dermatitis Treatment market size stood at round USD $3.14 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Atopic Dermatitis is an inflammatory skin disease. The degree of its severity varies from patient to patient. It usually begins in childhood and is mostly confined to the flexural surfaces of the body. It is highly prevalent. It is more commonly known as eczema. Itching, redness of the skin, cracking, weeping, etc. are symptoms of it. It is a long term disease. Low humidity, cold weather, seasonal allergies are the common causes of it. A pattern of the disease and its severity determine the kind of treatment it ought to receive



Market Drivers

Growing patient population, a lot of new product launches, climate change, and large pipeline products are the primary drivers of market growth. Very strict regulations and generic competition are the primary restraints of market growth